Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 174

1.

Conservative axillary surgery in breast cancer patients undergoing mastectomy: long-term results.

Cowher MS, Grobmyer SR, Lyons J, O'Rourke C, Baynes D, Crowe JP.

J Am Coll Surg. 2014 Apr;218(4):819-24. doi: 10.1016/j.jamcollsurg.2013.12.041. Epub 2014 Jan 17.

PMID:
24655877
[PubMed - indexed for MEDLINE]
2.

[Optimal treatment of the axilla after positive sentinel lymph node biopsy in early invasive breast cancer. Early results of the OTOASOR trial].

Sávolt A, Musonda P, Mátrai Z, Polgár C, Rényi-Vámos F, Rubovszky G, Kovács E, Sinkovics I, Udvarhelyi N, Török K, Kásler M, Péley G.

Orv Hetil. 2013 Dec 8;154(49):1934-42. doi: 10.1556/OH.2013.29765. Hungarian.

PMID:
24292111
[PubMed - indexed for MEDLINE]
3.

Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial.

Giuliano AE, Hunt KK, Ballman KV, Beitsch PD, Whitworth PW, Blumencranz PW, Leitch AM, Saha S, McCall LM, Morrow M.

JAMA. 2011 Feb 9;305(6):569-75. doi: 10.1001/jama.2011.90.

PMID:
21304082
[PubMed - indexed for MEDLINE]
4.

Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: the American College of Surgeons Oncology Group Z0011 randomized trial.

Giuliano AE, McCall L, Beitsch P, Whitworth PW, Blumencranz P, Leitch AM, Saha S, Hunt KK, Morrow M, Ballman K.

Ann Surg. 2010 Sep;252(3):426-32; discussion 432-3. doi: 10.1097/SLA.0b013e3181f08f32.

PMID:
20739842
[PubMed - indexed for MEDLINE]
5.

Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial.

Krag DN, Anderson SJ, Julian TB, Brown AM, Harlow SP, Costantino JP, Ashikaga T, Weaver DL, Mamounas EP, Jalovec LM, Frazier TG, Noyes RD, Robidoux A, Scarth HM, Wolmark N.

Lancet Oncol. 2010 Oct;11(10):927-33. doi: 10.1016/S1470-2045(10)70207-2.

PMID:
20863759
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Obesity is a risk factor for developing postoperative lymphedema in breast cancer patients.

Helyer LK, Varnic M, Le LW, Leong W, McCready D.

Breast J. 2010 Jan-Feb;16(1):48-54. doi: 10.1111/j.1524-4741.2009.00855.x. Epub 2009 Nov 2.

PMID:
19889169
[PubMed - indexed for MEDLINE]
7.

Surgical management of early stage invasive breast cancer: a practice guideline.

McCready D, Holloway C, Shelley W, Down N, Robinson P, Sinclair S, Mirsky D; Breast Cancer Disease Site Group of Cancer Care; Ontario's Program in Evidence-Based Care.

Can J Surg. 2005 Jun;48(3):185-94.

PMID:
16013621
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Routine completion axillary lymph node dissection for positive sentinel nodes in patients undergoing mastectomy is not associated with improved local control.

Crawford JD, Ansteth M, Barnett J, Glissmeyer M, Johnson NG.

Am J Surg. 2013 May;205(5):581-4; discussion 584. doi: 10.1016/j.amjsurg.2013.02.001.

PMID:
23592166
[PubMed - indexed for MEDLINE]
9.

Long-term follow-up of axillary node-positive breast cancer patients receiving adjuvant systemic therapy alone: patterns of recurrence.

Fisher BJ, Perera FE, Cooke AL, Opeitum A, Venkatesan V, Dar AR, Stitt L.

Int J Radiat Oncol Biol Phys. 1997 Jun 1;38(3):541-50.

PMID:
9231678
[PubMed - indexed for MEDLINE]
10.

Long-term morbidity of patients with early breast cancer after sentinel lymph node biopsy compared to axillary lymph node dissection.

Schulze T, Mucke J, Markwardt J, Schlag PM, Bembenek A.

J Surg Oncol. 2006 Feb 1;93(2):109-19.

PMID:
16425290
[PubMed - indexed for MEDLINE]
11.

Axillary node interventions in breast cancer: a systematic review.

Rao R, Euhus D, Mayo HG, Balch C.

JAMA. 2013 Oct 2;310(13):1385-94. doi: 10.1001/jama.2013.277804. Review.

PMID:
24084924
[PubMed - indexed for MEDLINE]
12.

Completion axillary lymph node dissection not required for regional control in patients with breast cancer who have micrometastases in a sentinel node.

Yegiyants S, Romero LM, Haigh PI, DiFronzo LA.

Arch Surg. 2010 Jun;145(6):564-9. doi: 10.1001/archsurg.2010.84.

PMID:
20566977
[PubMed - indexed for MEDLINE]
13.

Survival after negative sentinel lymph node biopsy in breast cancer at least equivalent to after negative extensive axillary dissection.

Kuijt GP, van de Poll-Franse LV, Voogd AC, Nieuwenhuijzen GA, Roumen RM.

Eur J Surg Oncol. 2007 Sep;33(7):832-7. Epub 2006 Dec 29.

PMID:
17197151
[PubMed - indexed for MEDLINE]
14.

Neoadjuvant chemotherapy in breast cancer significantly reduces number of yielded lymph nodes by axillary dissection.

Erbes T, Orlowska-Volk M, Zur Hausen A, Rücker G, Mayer S, Voigt M, Farthmann J, Iborra S, Hirschfeld M, Meyer PT, Gitsch G, Stickeler E.

BMC Cancer. 2014 Jan 3;14:4. doi: 10.1186/1471-2407-14-4.

PMID:
24386929
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

[Management of the axilla in breast cancer: evidences and unresolved issues].

Fodor J, Polgár C, Péley G, Németh G.

Orv Hetil. 2001 Sep 9;142(36):1941-50. Review. Hungarian.

PMID:
11680099
[PubMed - indexed for MEDLINE]
16.

Impact of the American College of Surgeons Oncology Group (ACOSOG) Z0011 trial on clinical management of the axilla in older breast cancer patients: a SEER-medicare analysis.

Caretta-Weyer H, Greenberg CG, Wilke LG, Weiss J, LoConte NK, Decker M, Steffens NM, Smith MA, Neuman HB.

Ann Surg Oncol. 2013 Dec;20(13):4145-52. doi: 10.1245/s10434-013-3193-1.

PMID:
23959051
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Evolution of axillary nodal staging in breast cancer: clinical implications of the ACOSOG Z0011 trial.

Shah-Khan M, Boughey JC.

Cancer Control. 2012 Oct;19(4):267-76. Review.

PMID:
23037494
[PubMed - indexed for MEDLINE]
Free Article
18.

The evolving role of axillary lymph node dissection in the modern era of breast cancer management.

Barry JM, Weber WP, Sacchini V.

Surg Oncol. 2012 Jun;21(2):143-5. doi: 10.1016/j.suronc.2011.02.004. Epub 2011 Mar 25. Review.

PMID:
21440434
[PubMed - indexed for MEDLINE]
19.

The influence of axillary reverse mapping related factors on lymphedema in breast cancer patients.

Ikeda K, Ogawa Y, Kajino C, Deguchi S, Kurihara S, Tashima T, Goto W, Nishiguchi Y, Tokunaga S, Fukushima H, Inoue T.

Eur J Surg Oncol. 2014 Jul;40(7):818-23. doi: 10.1016/j.ejso.2014.03.023. Epub 2014 Apr 15.

PMID:
24768416
[PubMed - indexed for MEDLINE]
20.

Can axillary reverse mapping avoid lymphedema in node positive breast cancer patients?

Tausch C, Baege A, Dietrich D, Vergin I, Heuer H, Heusler RH, Rageth C.

Eur J Surg Oncol. 2013 Aug;39(8):880-6. doi: 10.1016/j.ejso.2013.05.009. Epub 2013 Jun 2.

PMID:
23735162
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk